genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Cellular reprogramming
Drug Discovery
AstraZeneca, University of Cambridge Expand Functional Genomics Collaboration
News
Alzheimer’s Risk Increased by Microglia Mutation
Cancer
Breast Cancer Cells Use Basement Membrane Barrier to Become Invasive
Cancer
Gene Regulation Survey Spans 4,749 Prognostic Modules across 32 Cancer Types
Drug Discovery
Running Large-Scale CRISPR Screens in Human Neurons
Bioprocessing
hiPSC Reprogramming Mimics hESCs
News
Stem Cell Model Points to Alzheimer’s Disease Embryonic Origins
Cancer
Stem Cells and Reprogramming in Human Acute Leukemia
Genome Editing
Mastering Cell Identity in a Dish: The Power of Cellular Reprogramming
Cancer
Molecular Time Travel Helps Colon Cells Turn Cancerous
1
2
3
...
8
Page 1 of 8
Scroll Up
Scroll Up
